These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29549467)

  • 1. Influence of on-going treatment with angiotensin-converting enzyme inhibitor or angiotensin receptor blocker on the outcome of patients treated with intravenous rt-PA for ischemic stroke.
    Gilliot S; Sibon I; Mas JL; Moulin T; Béjot Y; Cordonnier C; Giroud M; Odou P; Bordet R; Vivien D; Leys D;
    J Neurol; 2018 May; 265(5):1166-1173. PubMed ID: 29549467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use.
    Lin SY; Tang SC; Tsai LK; Yeh SJ; Hsiao YJ; Chen YW; Chen KH; Yip BS; Shen LJ; Wu FL; Jeng JS
    Eur J Neurol; 2014 Oct; 21(10):1285-91. PubMed ID: 24909847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia.
    Myslimi F; Caparros F; Dequatre-Ponchelle N; Moulin S; Gautier S; Girardie P; Cordonnier C; Bordet R; Leys D
    Stroke; 2016 Jul; 47(7):1825-30. PubMed ID: 27197851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C; Bai Q; Zhao Z; Zhang J
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior vs. anterior circulation infarction: demography, outcomes, and frequency of hemorrhage after thrombolysis.
    Dorňák T; Král M; Hazlinger M; Herzig R; Veverka T; Buřval S; Šaňák D; Zapletalová J; Antalíková K; Kaňovský P
    Int J Stroke; 2015 Dec; 10(8):1224-8. PubMed ID: 26310390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Association Between Polymorphisms within PAI-1 and ACE genes and Ischemic Stroke Outcome After rt-PA Therapy.
    Dušanović Pjević M; Beslac Bumbaširevic L; Vojvodic L; Grk M; Maksimović N; Damnjanović T; Novaković I; Kačar K; Pesic M; Perovic D; Savic M; Maksic V; Trickovic J; Jekic B
    J Pharm Pharm Sci; 2019; 22(1):142-149. PubMed ID: 31013014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular treatment or general treatment: how should acute ischemic stroke patients choose to benefit from them the most?: A systematic review and meta-analysis.
    Yang W; Zhang L; Yao Q; Chen W; Yang W; Zhang S; He L; Li H; Zhang Y
    Medicine (Baltimore); 2020 May; 99(20):e20187. PubMed ID: 32443338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator.
    Liu SY; Cao WF; Wu LF; Xiang ZB; Liu SM; Liu HY; Pan Y; Nie F; Wu XM; Xie XF
    Medicine (Baltimore); 2018 Dec; 97(49):e13216. PubMed ID: 30544380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodinated Contrast Agents Reduce the Efficacy of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients: a Multicenter Cohort Study.
    Chen Z; Xu C; Zhong W; Gong X; Hu H; Zhang X; Chen Y; Li Q; Luo Z; Chen Z; Lou M
    Transl Stroke Res; 2021 Aug; 12(4):530-539. PubMed ID: 32895894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proportion of single-chain recombinant tissue plasminogen activator and outcome after stroke.
    Leys D; Hommet Y; Jacquet C; Moulin S; Sibon I; Mas JL; Moulin T; Giroud M; Sagnier S; Cordonnier C; Medeiros de Bustos E; Turc G; Ronzière T; Bejot Y; Detante O; Ouk T; Mendyk AM; Favrole P; Zuber M; Triquenot-Bagan A; Ozkul-Wermester O; Montoro FM; Lamy C; Faivre A; Lebouvier L; Potey C; Poli M; Hénon H; Renou P; Dequatre-Ponchelle N; Bodenant M; Debruxelles S; Rossi C; Bordet R; Vivien D;
    Neurology; 2016 Dec; 87(23):2416-2426. PubMed ID: 27815401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early epileptic seizures in ischaemic stroke treated by mechanical thrombectomy: influence of rt-PA.
    Ba K; Casolla B; Caparros F; Bricout N; Della Schiava L; Pasi M; Dequatre-Ponchelle N; Bodenant M; Bordet R; Cordonnier C; Hénon H; Leys D
    J Neurol; 2021 Jan; 268(1):305-311. PubMed ID: 32797298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?
    Kent DM; Hinchey J; Price LL; Levine SR; Selker HP
    Stroke; 2004 May; 35(5):1141-6. PubMed ID: 15087567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
    Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Thrombolysis for Stroke Patients with G6PD Deficiency.
    Wu X; Fu R; Tang Y; Shi L; Rong X; Guo J; Li J; Shen Q
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):2026-2031. PubMed ID: 29653805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
    Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
    Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy for stroke in patients with preexisting cognitive impairment.
    Murao K; Leys D; Jacquin A; Kitazono T; Bordet R; Béjot Y; Kimura K; Godefroy O; Wakisaka Y; Moulin S; Ago T; Sibon I; Bombois S; Mas JL; Hénon H; Pasquier F; Giroud M; Cordonnier C; Okada Y;
    Neurology; 2014 Jun; 82(23):2048-54. PubMed ID: 24827495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.